You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Express Scripts
Merck
McKesson
Moodys
Colorcon
Mallinckrodt

Last Updated: August 4, 2020

DrugPatentWatch Database Preview

MEPERIDINE HYDROCHLORIDE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Meperidine Hydrochloride patents expire, and when can generic versions of Meperidine Hydrochloride launch?

Meperidine Hydrochloride is a drug marketed by Abbott, Baxter Hlthcare, Igi Labs Inc, Intl Medication, Parke Davis, Watson Labs, West-ward Pharms Int, Hikma, Anda Repository, Barr, Duramed Pharms Barr, Epic Pharma, Specgx Llc, Sun Pharm Inds Inc, Sun Pharm Industries, Vintage Pharms, Wyeth Ayerst, Hospira, and Icu Medical Inc. and is included in forty-two NDAs.

The generic ingredient in MEPERIDINE HYDROCHLORIDE is meperidine hydrochloride. There are six drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the meperidine hydrochloride profile page.

US ANDA Litigation and Generic Entry Outlook for Meperidine Hydrochloride

A generic version of MEPERIDINE HYDROCHLORIDE was approved as meperidine hydrochloride by HIKMA on January 30th, 1985.

  Start Trial

Drug patent expirations by year for MEPERIDINE HYDROCHLORIDE
Recent Clinical Trials for MEPERIDINE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Rajesh DesharN/A
Makassed General HospitalN/A
University of WashingtonPhase 4

See all MEPERIDINE HYDROCHLORIDE clinical trials

Pharmacology for MEPERIDINE HYDROCHLORIDE
Drug ClassOpioid Agonist
Mechanism of ActionFull Opioid Agonists
Medical Subject Heading (MeSH) Categories for MEPERIDINE HYDROCHLORIDE

US Patents and Regulatory Information for MEPERIDINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Epic Pharma MEPERIDINE HYDROCHLORIDE meperidine hydrochloride TABLET;ORAL 040331-001 May 28, 1999 AA RX No Yes   Start Trial   Start Trial   Start Trial
Hikma MEPERIDINE HYDROCHLORIDE meperidine hydrochloride SYRUP;ORAL 088744-001 Jan 30, 1985 RX No Yes   Start Trial   Start Trial   Start Trial
Sun Pharm Industries MEPERIDINE HYDROCHLORIDE meperidine hydrochloride TABLET;ORAL 080448-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Watson Labs MEPERIDINE HYDROCHLORIDE PRESERVATIVE FREE meperidine hydrochloride INJECTABLE;INJECTION 073443-001 Mar 17, 1992 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKesson
Boehringer Ingelheim
Colorcon
Moodys
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.